Back to search

Article

Long-term Health Benefits to Newly Diagnosed Type-2 Diabetes from Short-term Continuous-subcutaneous Insulin Injection Therapy

2021-08-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Continuous-subcutaneous insulin injection (CSII) therapy to type 2 diabetes mellitus (T2DM) patients generated short-term health benefits. Our aims were to investigate long-term health benefits of CSII monotherapy, in combination with metformin and pioglitazone, or with sitagliptin. <bold>Methods</bold>In this randomized clinical trial, patients were treated for a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cad7250c-e257-5f68-8caf-495ea6772aca
DOI
10.21203/rs.3.rs-820692/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term Health Benefits to Newly Diagnosed Type-2 Diabetes from Short-term Continuous-subcutaneous Insulin Injection TherapyDOI 10.21203/rs.3.rs-820692/v1
Therapy-Driven Trajectories of Complications in Type 2 Diabetes Mellitus: A Comparative Observational Study of Standalone and Integrated Pharmacotherapy in a Tertiary Care Teaching HospitalSemantic proximity
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity
Evaluation of the effectiveness of in-hospital exercise rehabilitation in middle-aged and elderly patients with type 2 diabetes mellitus combined with sarcopenia Effect of lifestyle management on disease status in patients with type 2 diabetes mellitusSemantic proximity
Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life - A State-of-Art ReviewSemantic proximity
Fasting insulin predicts cardiovascular mortality in pre-diabetes and remains elevated across type 2 diabetes: An NHANES 2007–2018 cohort analysisSemantic proximity
Short- to Medium-Term Cost Burden of Type 2 Diabetes Mellitus Diagnosed in Middle Age: A Nationwide Cohort Study Comparing Individuals Aged 30–45 and 46–55 YearsSemantic proximity
Safety and effectiveness of SGLT2-inhibitors in people with type 2 diabetes over 70: UK population-based study using an Instrumental Variable approachSemantic proximity
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort studySemantic proximity
Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical dataSemantic proximity
Transition from CSII to Second-Generation Basal Insulin Analogues in Hospitalized T2DM Patients: A CGM-Based StudySemantic proximity
Liraglutide Use in A Real-World Setting: Patient Characteristics at Antidiabetic Treatment Initiation Modulate Cardiovascular Safety OutcomesSemantic proximity
Sugar Sweetened Beverages Attributable Disease Burden and the Potential Impact of Policy Interventions: A Systematic Review of Epidemiological and Decision ModelsSemantic proximity
Select a neighboring publication to make it the new centre.